Lee W, Wakasugi H, Ibayashi H
Gastroenterol Jpn. 1983 Oct;18(5):453-8. doi: 10.1007/BF02776585.
The somatostatin content in the pancreas and gastrointestinal tract was examined in normal, streptozotocin (STZ)-diabetic and pancreatic duct ligation (PDL) rats. The somatostatin content in the pancreas and gastric antrum in the STZ-diabetic group showed a higher concentration compared with those in the normal control group (p less than 0.001). The somatostatin content in the duodenum in the PDL group showed a higher concentration compared with those in the sham-operated group (p less than 0.02). There was no significant increase in the lower gastrointestinal tract in the normal, STZ and PDL groups. These facts suggest that the concentration of somatostatin varies according to tissues and organs and that the distribution of somatostatin in chronic pancreatic injury caused by PDL is different from that in diabetes mellitus cases or controls.
在正常大鼠、链脲佐菌素(STZ)诱导的糖尿病大鼠和胰管结扎(PDL)大鼠中检测了胰腺和胃肠道中的生长抑素含量。与正常对照组相比,STZ诱导的糖尿病组胰腺和胃窦中的生长抑素含量浓度更高(p<0.001)。与假手术组相比,PDL组十二指肠中的生长抑素含量浓度更高(p<0.02)。正常组、STZ组和PDL组的下消化道均无显著增加。这些事实表明,生长抑素的浓度因组织和器官而异,并且在PDL引起的慢性胰腺损伤中生长抑素的分布与糖尿病病例或对照组不同。